node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
C5orf46 | GPR87 | ENSP00000315370 | ENSP00000260843 | Uncharacterized protein C5orf46; Chromosome 5 open reading frame 46. | G-protein coupled receptor 87; Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage. Belongs to the G-protein coupled receptor 1 family. | 0.468 |
C5orf46 | WFDC5 | ENSP00000315370 | ENSP00000361875 | Uncharacterized protein C5orf46; Chromosome 5 open reading frame 46. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.581 |
ELF5 | WFDC5 | ENSP00000311010 | ENSP00000361875 | ETS-related transcription factor Elf-5; Transcriptionally activator that may play a role in regulating the later stages of keratinocytes terminal differentiation. Belongs to the ETS family. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.826 |
GADD45GIP1 | WFDC5 | ENSP00000323065 | ENSP00000361875 | Growth arrest and DNA damage-inducible proteins-interacting protein 1; Acts as a negative regulator of G1 to S cell cycle phase progression by inhibiting cyclin-dependent kinases. Inhibitory effects are additive with GADD45 proteins but occurs also in the absence of GADD45 proteins. Acts as a repressor of the orphan nuclear receptor NR4A1 by inhibiting AB domain-mediated transcriptional activity. May be involved in the hormone-mediated regulation of NR4A1 transcriptional activity. May play a role in mitochondrial protein synthesis; Belongs to the mitochondrion-specific ribosomal protei [...] | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.715 |
GPR87 | C5orf46 | ENSP00000260843 | ENSP00000315370 | G-protein coupled receptor 87; Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage. Belongs to the G-protein coupled receptor 1 family. | Uncharacterized protein C5orf46; Chromosome 5 open reading frame 46. | 0.468 |
GPR87 | WFDC5 | ENSP00000260843 | ENSP00000361875 | G-protein coupled receptor 87; Receptor for lysophosphatidic acid (LPA). Necessary for p53/TP53-dependent survival in response to DNA damage. Belongs to the G-protein coupled receptor 1 family. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.555 |
KRTDAP | WFDC5 | ENSP00000339251 | ENSP00000361875 | Keratinocyte differentiation-associated protein; May act as a soluble regulator of keratinocyte differentiation. May play an important role in embryonic skin morphogenesis. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.712 |
PI3 | SEMG1 | ENSP00000243924 | ENSP00000361867 | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | 0.730 |
PI3 | SEMG2 | ENSP00000243924 | ENSP00000361855 | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | 0.735 |
PI3 | WFDC12 | ENSP00000243924 | ENSP00000361871 | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | WAP four-disulfide core domain protein 12; Antibacterial protein. Putative acid-stable proteinase inhibitor. | 0.832 |
PI3 | WFDC5 | ENSP00000243924 | ENSP00000361875 | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.572 |
SEMG1 | PI3 | ENSP00000361867 | ENSP00000243924 | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | 0.730 |
SEMG1 | SEMG2 | ENSP00000361867 | ENSP00000361855 | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | 0.851 |
SEMG1 | WFDC12 | ENSP00000361867 | ENSP00000361871 | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | WAP four-disulfide core domain protein 12; Antibacterial protein. Putative acid-stable proteinase inhibitor. | 0.859 |
SEMG1 | WFDC5 | ENSP00000361867 | ENSP00000361875 | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.549 |
SEMG2 | PI3 | ENSP00000361855 | ENSP00000243924 | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | 0.735 |
SEMG2 | SEMG1 | ENSP00000361855 | ENSP00000361867 | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | Seminal basic protein; Predominant protein in semen. It participates in the formation of a gel matrix entrapping the accessory gland secretions and ejaculated spermatozoa. Fragments of semenogelin and/or fragments of the related proteins may contribute to the activation of progressive sperm movements as the gel-forming proteins are fragmented by KLK3/PSA. | 0.851 |
SEMG2 | WFDC12 | ENSP00000361855 | ENSP00000361871 | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | WAP four-disulfide core domain protein 12; Antibacterial protein. Putative acid-stable proteinase inhibitor. | 0.872 |
SEMG2 | WFDC5 | ENSP00000361855 | ENSP00000361875 | Semenogelin-2; Participates in the formation of a gel matrix (sperm coagulum) entrapping the accessory gland secretions and ejaculated spermatozoa. | WAP four-disulfide core domain protein 5; Putative acid-stable proteinase inhibitor. | 0.570 |
WFDC12 | PI3 | ENSP00000361871 | ENSP00000243924 | WAP four-disulfide core domain protein 12; Antibacterial protein. Putative acid-stable proteinase inhibitor. | Elafin; Neutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis. Has been shown to inhibit the alpha-4-beta-2/CHRNA2-CHRNB2 nicotinic acetylcholine receptor and to produce a weak inhibition on Kv11.1/KCNH2/ERG1 and on the transient receptor potential cation channel subfamily V member 1 (TRPV1). | 0.832 |